Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes
Coronavirus Disease 2019 (COVID-19), which has reached pandemic proportions. A …

Abstract Coronavirus disease 2019 (COVID‐19) has spread worldwide. To date, no specific
drug for COVID‐19 has been developed. Thus, this randomized, open‐label, controlled …

In only a few months after initial discovery in Wuhan, China, SARS-CoV-2 and the
associated coronavirus disease 2019 (COVID-19) have become a global pandemic causing …

The main discussion above of the novel pathogenic severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection has focused substantially on the immediate risks and …

Corona virus disease 2019 (COVID-19) has caused a global outbreak and severely posed
threat to people's health and social stability. Mounting evidence suggests that …

SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …

Background Patients with COVID-19 caused by SARS-CoV-2 exhibit diverse clinical
manifestations and severity including enteric involvement. Commensal gut bacteria can …

Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
and associated clinical sequelae requires well-coordinated metabolic and immune …

Background First vaccines for prevention of Coronavirus disease 2019 (COVID‐19) are
becoming available but there is a huge and unmet need for specific forms of treatment. In …

Background The emergence of the novel, pathogenic severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused a global health emergency. SARS-CoV-2 is highly …